Resources for observational comparative research have expanded enormously in recent years to include very large sources of ...

A new @HopkinsMedicine study of mice reveals that epigenetic marks can be inherited in ways that break the century-long ...

Sitting on low benches, casually talking, dressed in comfortable clothes, and surrounded by books, design objects, and works of art, Charles and Ray Eames appear in one of the most emblematic images ...

Objectives To evaluate the performance of large language models (LLMs) in risk of bias assessment and to examine whether ...

The European Medicines Agency (EMA) has finalized its reflection paper on a tailored clinical approach to biosimilar development, revising the wording on when it may waive the need for comparative ...

This paper presents the findings of the Siemens Healthineers SHIFT Innovation Pan-Africa Capacity Building Program, which aims to improve access and affordability of healthcare across Africa through ...

Abstract: Vision systems are nowadays based on smart cameras that are integrated into Industrial Control System (ICS) using Industrial Internet of Things (IIoT) principles. The information between ...

The FDA is revising biosimilar approval processes, eliminating "switching" and comparative efficacy studies, favoring analytical assessments. These changes could reduce development costs by 80%, ...

Our FDA: Drug & Device Team examines the FDA’s new draft guidance that allows biosimilar developers to rely more on analytical and pharmacokinetic data, reducing the need for costly and time-consuming ...

The Trump administration’s latest effort to lower drug costs is expanding to biosimilars, medications that are highly similar to biologic drugs made with or isolated from living organisms such as ...

Case studies serve as an excellent resource for devising innovative sales strategies, and providing insights into successful maneuvers and problem-solving techniques. Innovation Inspired by Proven ...